Annex

The Annex to Implementing Regulation (EU) No 686/2012 is amended as follows:

The following Part D is added:

‘PART D

Allocation of the evaluation of active substances whose approval expires between 31 March 2025 and 27 December 2028

Active substance	Rapporteur Member State	Co-rapporteur Member State
Alpha-cypermethrin	FR	AT
Bacillus amyloliquefaciens subsp. plantarum strain D747	NL	SK
Bacillus amyloliquefaciens strain MBI 600	NL	SK
Beauveria bassiana strain NPP111B005	BE	RO
Beauveria bassiana strain 147	BE	RO
Bentazone	PL	EL
Bordeaux mixture	IT	PL
Chromafenozide	CZ	MT
Copper hydroxide	IT	PL
Copper oxide	IT	PL
Copper oxychloride	IT	PL
Cyantraniliprole	ES	FI
Fenpicoxamid	SE	BG
Flupyradifurone	EL	PL
Gamma-cyhalothrin	DE	ES
Halauxifen-methyl	HU	SE
Isofetamid	PT	IE
Mandestrobin	SE	NO
Meptyldinocap	HR	DE
Methoxyfenozide	FR	HU
Metschnikowia fructicola strain NRRL Y-27328	NL	HR
Oxathiapiprolin	NO	CZ
Pinoxaden	FI	BE
Propyzamide	DK	DE
Rescalure	IE	PT
Sulfoxaflor	AT	ES
Terpenoid blend QRD 460	FR	DK
Tribasic copper sulphate	IT	PL

’